• Abstract Submission Deadline: December 04, 2025
  • Pre Early Bird Registration Ends: December 09, 2025

Transforming your ideas into digital reality

Sed ut perspiciatis unde omnis natus error voluptatem santium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab nllo inventore veritatis quasi architecto beatae vitae

Cancer R&D 2026 Experts

Raghu Kalluri Cancer
Raghu Kalluri

The University of Texas MD Anderson Cancer Center, TX

Dihua Yu Cancer
Dihua Yu

The University of Texas MD Anderson Cancer Center, TX

Michael B Yaffe Cancer
Michael B Yaffe

Massachusetts Institute of Technology, MA

Ying-Chih Chang Cancer
Ying-Chih Chang

CEO, Acrocyte Therapeutics Inc.
Taiwan

Stephen N Jones Cancer
Stephen N Jones

Frederick National Laboratory for Cancer Research, National Institutes of Health, MD

Geeta Upadhyay Cancer
Geeta Upadhyay

Uniformed Services University of the Health Sciences, MD

Julie H Ostrander Cancer
Julie H Ostrander

University of Minnesota
MN

David Alexander Potter Cancer
David Alexander Potter

University of Minnesota
MN

Peng Jiang Cancer
Peng Jiang

National Institutes of Health
MD

Qin Feng Cancer
Qin Feng

University of Houston
TX

Yan Peng Cancer
Yan Peng

University of Texas Southwestern Medical Center, TX

Ana M. Gamero Cancer
Ana M. Gamero

Lewis Katz School of Medicine at Temple University, PA

Dmitriy Minond Cancer
Dmitriy Minond

Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, FL